Common antidepressant may ease long COVID’s crushing fatigue
A low-cost antidepressant may offer new hope for people struggling with long COVID fatigue. In a randomized clinical trial involving 399 adults, fluvoxamine significantly reduced fatigue and improved quality of life compared with a placebo, making it one of the first medications to show meaningful benefits for this disabling condition.
The health section covers stories about medical progress, recovery, and wellbeing. We look for genuine advances: new therapies clearing regulatory hurdles, diseases being eradicated in specific regions, communities improving public health outcomes through evidence-based programs. Celebrity wellness trends and supplement marketing do not make the cut.
A new experimental treatment may have found a way to outsmart glioblastoma’s toughest defense: the blood-brain barrier. …
A drug originally developed for spinal cord injury may offer a fresh approach to treating Alzheimer’s disease. In mouse …
Insomnia breakthrough as experts discover key 'driver' of sleep problem that ruins millions of lives MSN
Maricopa County in Arizona has some of the hottest temperatures, but it has reduced the number of heat-related deaths.